No effect of depression on [15O]H2O PET response to intravenous d- fenfluramine

American Journal of Psychiatry

Volumn 155, Issue 9, 1998, Pages 1241-1246

  Meyer, Jeffrey H ^a   Kennedy, Sidney ^a   Brown, Gregory M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; HYDROCORTISONE; OXYGEN; SEROTONIN; WATER;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BLOOD; BLOOD FLOW; BRAIN; COGNITION; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG EFFECT; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SCINTISCANNING; VASCULARIZATION;

ADMINISTRATION, ORAL; ADULT; BRAIN; COGNITION; DEPRESSIVE DISORDER; FEMALE; FENFLURAMINE; FLUORODEOXYGLUCOSE F18; HUMANS; HYDROCORTISONE; INJECTIONS, INTRAVENOUS; OXYGEN RADIOISOTOPES; PSYCHOMOTOR PERFORMANCE; REGIONAL BLOOD FLOW; SEROTONIN; TOMOGRAPHY, EMISSION-COMPUTED; WATER;

EID: 0031595808     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.9.1241     Document Type: Article

References (36)

1. Agren H, Reibring L: PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 1994; 27:2-6
2. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR: Serotonin function and the mechanism of antidepressant action, reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990; 47:411-418
3. Asberg M, Traskman L, Thoren P: 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry 1976; 33:1193-1197
4. 2 receptor changes in major depression. Biol Psychiatry 1990; 27:489-496
5. Hrdina PD, Demeter E, Vu TB, Sotonyi P, Palkovits M: 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res 1993; 614:37-44
6. McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK, Eccleston D: 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Disord 1987; 13:67-74
7. D'haenen H, Bossuyt A, Mertens J, Bossuyt-Piron C, Gijsemans M, Kaufman L: SPECT imaging of serotonin2 receptors in depression. Psychiatry Res 1992; 45:227-237
8. 2 receptor binding sites in depressed suicide victims. Brain Res 1988; 443:272-280
9. Crow TJ, Cross AJ, Cooper SJ, Deakin JF, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R, Corsellis JAN, Chambers DR, Blessed G, Perry EK, Perry RH, Tomlinson BE: Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 1984; 23: 1561-1569
10. 2 serotonin receptors after stroke: lateralized changes and relationship to depression. Am J Psychiatry 1988; 145:937-943
11. Invernizzi R, Berettera C, Garattini S, Samanin R: D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol 1986; 120:9-15
12. Bonnano G, Fassio A, Severi P, Ruelle A, Raiteri M: Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism. J Neurochem 1994; 63:1163-1166
13. Heninger GR, Charney DS, Sternberg DE: Serotonergic function in depression. Arch Gen Psychiatry 1984; 41:398-402
14. Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S: Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci 1984; 34:1029-1039
15. Lopez-Ibor JJ, Saiz-Ruiz J, Iglesias LM: The fenfluramine challenge test in the affective spectrum: a possible marker of endogeneity and severity. Pharmacopsychiatry 1988; 21:9-14
16. Malone KM, Thase ME, Mieczkowski T, Myers JE, Stull SD, Cooper TB, Mann JJ: Fenfluramine challenge test as a predictor of outcome in major depression. Psychopharmacol Bull 1993; 29:155-161
17. Kapur S, Meyer J, Wilson AA, Houle S, Brown GM: Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans. Brain Res 1994; 646:292-294
18. 2O PET study in humans. Neurosci Lett 1996; 207:25-28
19. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA: Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 1996; 153:174-182
20. Mann JJ, Malone KM, Diehl DJ, Perel J, Nichols TE, Mintun MA: Positron emission tomography imaging of serotonin activation effects on prefrontal cortex in healthy volunteers. J Cereb Blood Flow Metab 1996; 16:418-426
21. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2. New York, New York State Psychiatric Institute, Biometrics Research, 1995
22. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
23. 2O PET study in humans. Neurosci Lett 1994; 176:21-24
24. 15O]water PET studies. J Cereb Blood Flow Metab 1994; 14:423-430
25. Friston KJ, Frith CD, Liddle PF, Frackowiak RS: Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991; 4:690-699
26. Friston KJ, Ashburner J, Pollne JB, Frith CD, Heather JD, Frackowiak RSJ: Spatial realignment and normalization of images. Human Brain Mapping 1995; 1:165-189
27. Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ: Assessing the significance of focal activations using their spatial extent. Human Brain Mapping 1994; 1:214-220
28. Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RSJ: Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping 1995; 2: 189-210
29. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. New York, Thieme Medical, 1988
30. Kennedy SH, Javanmard M, Vaccarino FJ: A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Can J Psychiatry 1997; 42:467-475
31. Duhault J, Beregi L, Roman R: Substituted phenethylamines and anorexia. Prog Neuropsychopharmacol 1980; 4:341-349
32. Fuller RW, Snoddy HD, Hemrick SK: Effects of fenfluramine and norfenfluramine on brain serotonin metabolism in rats. Proc Soc Exp Biol Med 1978; 157:202-205
33. Parsons AA, Whalley ET, Feniuk W, Connor HE, Humphrey PP: 5-HT1 like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol 1989; 96:434-449
34. Hamel E, Bouchard D: Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites. Br J Pharmacol 1991; 102:227-233
35. Jansen I, Olesen J, Edvinsson I: 5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol Scand 1993; 147:141-150
36. McBean DE, Sharkley J, Ritchie IM, Kelly PAT: Cerebrovascular and functional consequences of 5-HT1A receptor activation. Brain Res 1991; 555:159-163